A detailed history of Legato Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Legato Capital Management LLC holds 5,072 shares of GKOS stock, worth $759,176. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,072
Previous 4,540 11.72%
Holding current value
$759,176
Previous $537,000 22.91%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$113.62 - $135.39 $60,445 - $72,027
532 Added 11.72%
5,072 $660,000
Q2 2024

Jul 26, 2024

SELL
$89.48 - $118.35 $453,842 - $600,271
-5,072 Reduced 52.77%
4,540 $537,000
Q1 2024

Apr 15, 2024

BUY
$76.4 - $96.33 $453,739 - $572,103
5,939 Added 161.69%
9,612 $906,000
Q4 2023

Jan 16, 2024

SELL
$59.53 - $85.11 $80,484 - $115,068
-1,352 Reduced 26.91%
3,673 $291,000
Q3 2023

Oct 12, 2023

BUY
$69.23 - $79.09 $347,880 - $397,427
5,025 New
5,025 $378,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.12B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.